These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite. Balcer LJ; Baier ML; Cohen JA; Kooijmans MF; Sandrock AW; Nano-Schiavi ML; Pfohl DC; Mills M; Bowen J; Ford C; Heidenreich FR; Jacobs DA; Markowitz CE; Stuart WH; Ying GS; Galetta SL; Maguire MG; Cutter GR Neurology; 2003 Nov; 61(10):1367-73. PubMed ID: 14638957 [TBL] [Abstract][Full Text] [Related]
4. Contrast letter acuity as a measure of visual dysfunction in patients with Friedreich ataxia. Lynch DR; Farmer JM; Rochestie D; Balcer LJ J Neuroophthalmol; 2002 Dec; 22(4):270-4. PubMed ID: 12464730 [TBL] [Abstract][Full Text] [Related]
5. The King-Devick (K-D) test of rapid eye movements: a bedside correlate of disability and quality of life in MS. Moster S; Wilson JA; Galetta SL; Balcer LJ J Neurol Sci; 2014 Aug; 343(1-2):105-9. PubMed ID: 24954088 [TBL] [Abstract][Full Text] [Related]
6. Recognition of motion-defined shapes in patients with multiple sclerosis and optic neuritis. Regan D; Kothe AC; Sharpe JA Brain; 1991 Jun; 114 ( Pt 3)():1129-55. PubMed ID: 2065244 [TBL] [Abstract][Full Text] [Related]
7. Evaluating loss of visual function in multiple sclerosis as measured by low-contrast letter acuity. Balcer LJ; Frohman EM Neurology; 2010 Apr; 74 Suppl 3():S16-23. PubMed ID: 20421569 [TBL] [Abstract][Full Text] [Related]
8. Relation of vision to global and regional brain MRI in multiple sclerosis. Wu GF; Schwartz ED; Lei T; Souza A; Mishra S; Jacobs DA; Markowitz CE; Galetta SL; Nano-Schiavi ML; Desiderio LM; Cutter GR; Calabresi PA; Udupa JK; Balcer LJ Neurology; 2007 Dec; 69(23):2128-35. PubMed ID: 17881718 [TBL] [Abstract][Full Text] [Related]
9. Agreement analysis comparing iPad LCVA and Sloan testing in multiple sclerosis patients. Sattarnezhad N; Farrow S; Kimbrough D; Glanz B; Healy B; Chitnis T Mult Scler; 2018 Jul; 24(8):1126-1130. PubMed ID: 28585909 [TBL] [Abstract][Full Text] [Related]
10. The SKILL Card. An acuity test of reduced luminance and contrast. Smith-Kettlewell Institute Low Luminance. Haegerstrom-Portnoy G; Brabyn J; Schneck ME; Jampolsky A Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):207-18. PubMed ID: 9008645 [TBL] [Abstract][Full Text] [Related]
11. Diffusion tensor imaging correlates of visual impairment in multiple sclerosis and chronic optic neuritis. Kolbe SC; Marriott M; Walt Av; Fielding J; Klistorner A; Mitchell PJ; Butzkueven H; Kilpatrick TJ; Egan GF Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):825-32. PubMed ID: 22247457 [TBL] [Abstract][Full Text] [Related]
12. Visual acuity is associated with performance on visual and non-visual neuropsychological tests in multiple sclerosis. Feaster HT; Bruce JM Clin Neuropsychol; 2011 May; 25(4):640-51. PubMed ID: 21512957 [TBL] [Abstract][Full Text] [Related]
13. Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis. Baier ML; Cutter GR; Rudick RA; Miller D; Cohen JA; Weinstock-Guttman B; Mass M; Balcer LJ Neurology; 2005 Mar; 64(6):992-5. PubMed ID: 15781814 [TBL] [Abstract][Full Text] [Related]
14. Comparison of visual acuity charts in young adults and patients with diabetic retinopathy. Plainis S; Kontadakis G; Feloni E; Giannakopoulou T; Tsilimbaris MK; Pallikaris IG; Moschandreas J Optom Vis Sci; 2013 Feb; 90(2):174-8. PubMed ID: 23314130 [TBL] [Abstract][Full Text] [Related]
15. Natalizumab reduces visual loss in patients with relapsing multiple sclerosis. Balcer LJ; Galetta SL; Calabresi PA; Confavreux C; Giovannoni G; Havrdova E; Hutchinson M; Kappos L; Lublin FD; Miller DH; O'Connor PW; Phillips JT; Polman CH; Radue EW; Rudick RA; Stuart WH; Wajgt A; Weinstock-Guttman B; Wynn DR; Lynn F; Panzara MA Neurology; 2007 Apr; 68(16):1299-304. PubMed ID: 17438220 [TBL] [Abstract][Full Text] [Related]
16. Slope of psychometric functions and termination rule analysis for low contrast acuity charts. Carkeet A; Bailey IL Ophthalmic Physiol Opt; 2017 Mar; 37(2):118-127. PubMed ID: 28211180 [TBL] [Abstract][Full Text] [Related]
17. Utilization of Visual Acuity Retroilluminated Charts for the Assessment of Afferent Visual System Dysfunction in a Pediatric Neuroimmunology Population. Sguigna PV; McCreary MC; Conger DL; Graves JS; Benson LA; Waldman AT; Greenberg BM; J Neuroophthalmol; 2021 Mar; 41(1):19-23. PubMed ID: 32868561 [TBL] [Abstract][Full Text] [Related]
19. Clinical assessment of two new contrast sensitivity charts. Thayaparan K; Crossland MD; Rubin GS Br J Ophthalmol; 2007 Jun; 91(6):749-52. PubMed ID: 17166891 [TBL] [Abstract][Full Text] [Related]
20. Value of Pelli-Robson contrast sensitivity chart for evaluation of visual system in multiple sclerosis patients. Wender M Neurol Neurochir Pol; 2007; 41(2):141-3. PubMed ID: 17530576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]